Profiling the physiological pitfalls of anti-hepatitis C direct-acting agents in budding yeast
{{output}}
Sofosbuvir and Daclatasvir are among the direct-acting antiviral (DAA) medications prescribed for the treatment of chronic hepatitis C (CHC) virus infection as combination therapy with other antiviral medications. DAA-based therapy achieves high cure rates, re... ...
